Drug Profile
Alendronic acid
Alternative Names: Adronat; AHButBP; Alend; Alendronate; Alendronate disodium; Alendronate sodium hydrate; Alendros; Bonalon; Bonalon Jelly; Dronal; Fosalan; Fosamax; G 704650; GTH 42; GTH-42J; GTH-42V; GTH-42W; L 670452; Marvil; MK 217; Onclast; Osteosan®; Sodium alendronate trihydrate; TeirocLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Gador; Istituto Gentili
- Developer Teijin Pharma
- Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
- Mechanism of Action Osteoclast inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Corticosteroid-induced osteoporosis; Fracture; Male osteoporosis; Malignant hypercalcaemia; Osteitis deformans; Osteoporosis; Postmenopausal osteoporosis
- No development reported Bone resorption